Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: A meta-analysis

Cancer Epidemiology

Volumn 36, Issue 2, 2012, Pages

  Saadat, Mostafa ^a  

^a SHIRAZ UNIVERSITY   (Iran)

Author keywords

Breast cancer; Meta analysis; Paraoxonase 1; PON1; Susceptibility

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; META ANALYSIS; PRIORITY JOURNAL;

ARYLDIALKYLPHOSPHATASE; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84858792157     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.10.015     Document Type: Article

References (16)

1. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993, 3:73-76.
2. Leviev I., Deakin S., James R.W. Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. J Lipid Res 2001, 42:528-535.
3. Stevens V.L., Rodriguez C., Pavluck A.L., Thun M.J., Calle E.E. Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2006, 15:1226-1228.
4. Aĝaçhan B., Yayli{dotless}m I., Ergen H.A., Ari{dotless}kan S., Küçücük S., Yi{dotless}lmaz H., et al. Is paraoxonase1 192 BB genotype risk factor for breast cancer?. Adv Mol Med 2006, 2:37-40.
5. Gallicchio L., McSorley M.A., Newschaffer C.J., Huang H.Y., Thuita L.W., Hoffman S.C., et al. Body mass, polymorphisms in obesity-related genes, and the risk of developing breast cancer among women with benign breast disease. Cancer Detect Prev 2007, 31:95-101.
6. Antognelli C., Del Buono C., Ludovini V., Gori S., Talesa V.N., Crinò L., et al. CYP17GSTP1PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 2009, 9:115.
7. Naidu R., Har Y.C., Taib N.A. Genetic polymorphisms of paraoxonase 1 (PON1) gene: association between L55M or Q192R with breast cancer risk and clinico-pathological parameters. Pathol Oncol Res 2010, 16:533-540.
8. Hussein Y.M., Gharib A.F., Etewa R.L., ElSawy W.H. Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance. Mol Cell Biochem 2011, 351:117-123.
9. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
10. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
11. Liu C., Liu L. Polymorphisms in three obesity-related genes (LEPLEPR, and PON1) and breast cancer risk: a meta-analysis. Tumour Biol. 2011, (September). [Epub ahead of print]. 10.1007/s13277-011-0227-9.
12. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005, 14:1810-1818.
13. Kiyohara C., Takayama K., Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006, 54:267-283.
14. Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci 2006, 97:505-509.
15. Saadat M., Ansari-Lari M. Genetic polymorphism of glutathione S-transferase T1, M1 and asthma, a meta-analysis of the literature. Pak J Biol Sci 2007, 10:4183-4189.
16. Saadat M., Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 2009, 115:137-144.